Sentinelle Radar
Monday, November 9, 2026
Advancement dominated the day: RVMD moved up a stage, while HBM, OGC, GMAB and BTO.TO each pushed deeper into the pipeline, trailed by a long list of smaller names doing the same. On the leaderboard UROY, PSK.TO and KRYS hold the top ranks, though DPM.TO carries the only perfect Sentinelle score among them.
What changed overnight
-
Moved up a stage in the Sentinelle pipeline
The strongest of today's advancers, putting an oncology name with real index ambitions into the window where institutional buying typically shows up.
In the news: Revolution Medicines rises on Q3 beats; maintains 2026 guidance -
Moved up a stage in the Sentinelle pipeline
A move deeper into the pipeline places this copper producer where accumulation patterns tend to be more persistent than speculative.
-
Moved up a stage in the Sentinelle pipeline
Advancing further in the pipeline extends the day's gold-sector theme and marks sustained institutional interest rather than a single-session move.
In the news: OceanaGold Corporation Non-GAAP EPS of $0.94 misses by $0.29, revenue of $655M misses by $224.63M -
Moved up a stage in the Sentinelle pipeline
The only large biotech to advance this far today, suggesting the accumulation signal here has held long enough to deepen.
-
Moved up a stage in the Sentinelle pipeline
Another gold producer moving deeper in the pipeline, reinforcing that the sector's bid is broad rather than confined to one name.
In the news: B2Gold Non-GAAP EPS of $0.14 beats by $0.02, revenue of $836M beats by $7.1M -
Moved up a stage in the Sentinelle pipeline
An industrial distributor moving up a stage is the kind of unglamorous name where early institutional positioning often goes unnoticed.
-
Moved up a stage in the Sentinelle pipeline
Advancing a stage means the signal in this crypto-infrastructure name is now structural enough to separate from ordinary digital-asset volatility.
In the news: Hut 8 stock dips as digital asset losses hit Q3 profitability -
Moved up a stage in the Sentinelle pipeline
A small-cap gene therapy developer moving up a stage is where index-track accumulation is hardest to spot from price alone.
-
Moved up a stage in the Sentinelle pipeline
A stage advance for a commercial-stage specialty pharma name worth monitoring as float tightens.
In the news: Why is Liquidia stock gaining today? -
Moved up a stage in the Sentinelle pipeline
A compound semiconductor supplier moving up a stage adds a hardware name to a list otherwise dominated by biotech and mining.
-
Moved up a stage in the Sentinelle pipeline
Online gaming operator advancing a stage, a consumer-facing name where index eligibility and institutional ownership often move together.
-
Moved up a stage in the Sentinelle pipeline
A digital forensics vendor moving up a stage brings a defensive software profile into the watch set.
-
Moved up a stage in the Sentinelle pipeline
A cyclical flooring manufacturer moving up a stage suggests accumulation beginning ahead of any obvious operating turn.
-
Moved up a stage in the Sentinelle pipeline
A stage advance for a rare-disease developer where ownership concentration tends to build quietly before catalysts.
In the news: Agios Pharmaceuticals Q3 2026 Earnings Preview -
Moved up a stage in the Sentinelle pipeline
A women's health spinoff moving up a stage, a category where index repositioning can follow long after the separation.
-
Moved up a stage in the Sentinelle pipeline
Tanker shipping moving up a stage adds a rate-sensitive cyclical to a day otherwise skewed toward healthcare and metals.
-
Moved up a stage in the Sentinelle pipeline
A consumer fintech moving up a stage is worth watching given how quickly institutional ownership can shift in small-cap financials.
In the news: Dave stock slumps as Q3 profit trails estimates regardless of higher revenue, raised guidance -
Moved up a stage in the Sentinelle pipeline
A stage advance for a medical imaging small cap where any sustained institutional bid is meaningful against a thin base.
-
Moved up a stage in the Sentinelle pipeline
A theatre operator moving up a stage, a name whose index relevance depends on holding this accumulation through the cycle.
In the news: Here are Thursday's biggest analyst calls: SpaceX, Nvidia, First Solar, Nike, JetBlue, Cisco, Cinemark & more -
Moved up a stage in the Sentinelle pipeline
A hotel REIT closing out the day's advancers, where real-estate index flows can reinforce an existing bid.
In the news: Sunstone Hotel Investors, Inc. 5.70% CUM PFD I declares $0.3562 dividend
The 20 most significant of 125 changes overnight.
Leaderboard
| # | Company | Heading to |
|---|---|---|
| 1 | UROY Uranium Royalty Corp. | S&P 500 / Nasdaq-100 |
| 2 | PSK.TO PrairieSky Royalty Ltd | S&P/TSX 60 |
| 3 | KRYS Krystal Biotech, Inc. | S&P 500 / Nasdaq-100 |
| 4 | DPM.TO DPM Metals Inc. | S&P/TSX 60 |
| 5 | ADC Agree Realty Corp | S&P 500 / Nasdaq-100 |
| 6 | LGND Ligand Pharmaceuticals Inc | S&P 500 / Nasdaq-100 |
| 7 | CTRE CareTrust REIT, Inc. | S&P 500 / Nasdaq-100 |
| 8 | WCP.TO Whitecap Resources Inc. | S&P/TSX 60 |
| 9 | HQY Healthequity, Inc. | S&P 500 / Nasdaq-100 |
| 10 | JAZZ Jazz Pharmaceuticals plc | S&P 500 / Nasdaq-100 |
What is Sentinelle Radar?
Sentinelle follows companies on the path to a bigger index: US stocks that could join the S&P 500 or the Nasdaq-100, Toronto-listed stocks that could enter the S&P/TSX 60, and TSX Venture companies that could graduate to the main board. Every night, each company is scored on a set of financial ratios and on its ownership and trading profile, and placed along the pipeline. The Radar shows what changed overnight and the companies leading the list.
- Stage up: the company moved further along the pipeline.
- Perfect score: the company meets every criterion of Sentinelle's quality checklist.
- Only companies that clear Sentinelle's quality bar appear here, ranked by how well they fit the profile of an index candidate.
Comments are written by AI from the computed changes; every fact shown comes from the scoring itself.
Not investment advice. Sentinelle is an automated screen and can be wrong. The author may hold positions in companies mentioned.